Peripheral markers of brain damage and blood-brain barrier dysfunction - Wikidata - wikimedia - TriplyDB

Peripheral markers of brain damage and blood-brain barrier dysfunction

Peripheral markers of brain damage and blood-brain barrier dysfunction

http://www.wikidata.org/entity/Q33789473

about

Extracranial sources of S100B do not affect serum levels Pathophysiological impact of cigarette smoke exposure on the cerebrovascular system with a focus on the blood-brain barrier: expanding the awareness of smoking toxicity in an underappreciated area Pathobiology of tobacco smoking and neurovascular disorders: untied strings and alternative products Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier Serum S100B: a potential biomarker for suicidality in adolescents?Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions ProApolipoprotein A1: a serum marker of brain metastases in lung cancer patients Dynamic in vivo imaging of cerebral blood flow and blood-brain barrier permeability.Emerging concepts in acute mountain sickness and high-altitude cerebral edema: from the molecular to the morphological Improving the clinical management of traumatic brain injury through the pharmacokinetic modeling of peripheral blood biomarkers Cortisol is an associated-risk factor of brain dysfunction in patients with severe sepsis and septic shock Validation of serum markers for blood-brain barrier disruption in traumatic brain injury.Is peripheral immunity regulated by blood-brain barrier permeability changes?Seizure-promoting effect of blood-brain barrier disruption.Blood levels of S-100 calcium-binding protein B, high-sensitivity C-reactive protein, and interleukin-6 for changes in depressive symptom severity after coronary artery bypass grafting: prospective cohort nested within a randomized, controlled trial Vascular pathology and blood-brain barrier disruption in cognitive and psychiatric complications of type 2 diabetes mellitus.Significance of ubiquitin carboxy-terminal hydrolase L1 elevations in athletes after sub-concussive head hits Trajectory analysis of serum biomarker concentrations facilitates outcome prediction after pediatric traumatic and hypoxemic brain injury S100B blood levels and childhood trauma in adolescent inpatients S100β as a novel and accessible indicator for the presence of monocyte-driven encephalitis in AIDS Ghrelin prevents disruption of the blood-brain barrier after traumatic brain injury.Circulating damage marker profiles support a neuroprotective effect of erythropoietin in ischemic stroke patients A lack of association between elevated serum levels of S100B protein and autoimmunity in autistic children.Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke.Depressive symptoms are associated with tumor necrosis factor alpha in systemic lupus erythematosus.Biomarkers of brain injury in the premature infant.Re-exposure to the hypobaric hypoxic brain injury of high altitude: plasma S100B levels and the possible effect of acclimatisation on blood-brain barrier dysfunction.Cerebral perfusion in sepsis-associated delirium.The prognostic value of biomarkers in stroke.Does Systemic Inflammation Play a Role in Pediatric Psychosis?Mobile and cordless telephones, serum transthyretin and the blood-cerebrospinal fluid barrier: a cross-sectional study The Serum Concentration of the Calcium Binding Protein S100B is Positively Associated with Cognitive Performance in Older Adults Serum S100B represents a new biomarker for mood disorders.S100 calcium binding protein B as a biomarker of delirium duration in the intensive care unit - an exploratory analysis.Molecular biomarkers in stroke diagnosis and prognosis.Breaching the blood-brain barrier as a gate to psychiatric disorder.Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy.Mood disorders are glial disorders: evidence from in vivo studies.Endothelial Activation and Blood-Brain Barrier Injury as Risk Factors for Delirium in Critically Ill Patients.Can S100B Predict Cerebral Vasospasms in Patients Suffering from Subarachnoid Hemorrhage?

P2860

Q22241536-397335D5-F44C-4A5E-A387-C6729D9C9EC4 Q24627871-66A45EE3-96BB-4EC2-B6BA-EFE69A866268 Q26777643-ED8251BA-81FF-49EF-BCB0-B0C45136DA43 Q28550363-49DEBDA7-4D75-401A-928F-9F5CE786C43A Q28751578-EA198D99-8BA8-43BA-A174-045012B4A16F Q30432850-5E469447-3145-4200-A872-45FD4A51C04C Q30485388-7FDC4265-7C1F-428D-9522-85808D065307 Q30539584-9603A18E-317E-46D8-A4FA-FBEF59F08289 Q33504619-95BF6993-BB6E-44E4-816F-5402C5A4BB8F Q33595790-CBF8D892-7ACE-4ECE-8110-784192C3793A Q33616353-EE3F153B-4CD4-4B92-9AB7-4CC0DEC17F79 Q33657728-6CA29172-C011-424C-9B61-6A799F782530 Q33838466-B204002D-2F07-40C9-83F1-9C51D1E113EC Q34056074-B3F4895B-94CF-4D0E-A6C8-B2541FB740CC Q34374437-1128CCE7-FC75-450E-994F-D001F9846D39 Q34590922-02496598-6582-424B-8DB2-9206C4572638 Q35164692-9D723FDB-508C-40F9-B137-D5C66F4B68DA Q35547437-60A78996-5066-4803-A73B-89BA2C805FD5 Q35551126-15652D9C-71FE-4C3C-8C8E-CA34EF850423 Q35603172-A08F6AAF-79FF-44A8-B953-41D4A03ED610 Q35757736-4BEF2994-4653-40C2-B0A3-4B14D51884A9 Q35876807-64DD830B-311A-44B7-9A1E-DD97C675C4E7 Q35984262-B5DE6DFF-FA26-4701-95A3-05F21B39A4C8 Q36142617-54848AA4-BF78-4B7E-9ADB-6D469780532D Q36433143-4486EDD5-C43D-461C-B1FA-D526A3739DB9 Q36550723-11C69888-EBCF-4F5D-BFF1-BDFEA1994D6F Q36762408-C3CB4988-1071-40DE-8E92-FE580063CEA3 Q36787193-724E7391-FB53-48AC-842A-B54729C53F59 Q36949982-EEE00CCD-6239-43BB-B025-B4CD040D1237 Q36986370-96465EAC-8FF5-45D7-BD9F-501083030FB8 Q37184225-26E5E9D6-299E-4F3E-ACFF-E19C1D972B0C Q37205890-024A0BE3-BBE5-4AE0-9CFA-B24B98CEED4C Q37290664-B1CB7256-C0DD-4781-8585-8AAA9834BD60 Q37373277-0F399AEE-E1EE-4729-9A60-0E6AE169DC13 Q37408830-9DBECC99-0216-4089-97FA-5C2369003F63 Q37417409-C92A95E5-F937-4840-B5FB-FE6D82721631 Q37442196-DB85FD84-4816-4BD6-B2C6-BD0AA982414D Q37768341-1830FEFE-9FD7-420E-AE4B-7A8DBDAFA89A Q38879912-43495D58-FD3C-4F2F-BC70-9A68542C35D9 Q42137303-716B189B-AAB6-4424-BCA0-23F37DA8AC6B

P2860

Peripheral markers of brain damage and blood-brain barrier dysfunction

http://www.wikidata.org/entity/Q33789473

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Peripheral markers of brain damage and blood-brain barrier dysfunction

@ast

Peripheral markers of brain damage and blood-brain barrier dysfunction

@en

type

label

Peripheral markers of brain damage and blood-brain barrier dysfunction

@ast

Peripheral markers of brain damage and blood-brain barrier dysfunction

@en

prefLabel

Peripheral markers of brain damage and blood-brain barrier dysfunction

@ast

Peripheral markers of brain damage and blood-brain barrier dysfunction

@en

P1433

Q33789473-96FB1770-6C69-411B-9D43-B66B6226AFBB

P1476

Q33789473-D32CF5CF-5938-46C8-9A8C-FC1F29BFFF9B

P2093

Q33789473-0D790F2C-E472-464E-8729-033DAF82A9EF

Q33789473-1B0FB3BE-CCFC-4630-8F71-86270AEFA8F2

Q33789473-572C3FC3-6B6C-49D1-8A59-3C596D413690

Q33789473-63E49F3F-D401-46DE-8920-61DF5F230FD5

Q33789473-67CDE977-E346-4361-B1D6-256C1B68CC60

Q33789473-711F45CF-D50E-49AF-B2DA-F80DA9E4AEFA

Q33789473-8A1E6E01-3102-4484-9ACD-34E63FC1905C

Q33789473-8FC6C693-114E-4411-A28C-27EFD4494DA0

Q33789473-A41F1E83-5620-4B31-8987-9F835C08B8F6

Q33789473-AAE1431B-AF03-475C-8BF9-DC78FAB59E06

P2860

Q33789473-054570C9-FC5F-43D5-911E-C40A4477DD0F

Q33789473-1281B6BA-F619-42C6-8041-E668DE2ED623

Q33789473-19F5F41A-53C5-4184-BDD0-3D47EDC05F5C

Q33789473-21B098E2-440A-4DD2-8545-C2223FCD9349

Q33789473-2586CB06-5CEE-498B-B07D-243432779755

Q33789473-27CE87A7-7F97-4AC6-BAEA-FB114F8E59E7

Q33789473-28C292F7-F3C2-43E2-BD81-5E21CB813F51

Q33789473-2BEE8860-B379-4FE3-94B5-3757B07398ED

Q33789473-302ED2F4-27EA-45ED-8738-E6EC609FB0D2

Q33789473-31D34358-DC86-4AE2-ABF8-D1A4152329DD

P304

Q33789473-6EDF1B9B-B455-4938-91A9-566AA93BBF2C

P31

Q33789473-BA997979-AB33-4110-9743-F91F70F5C6D9

P433

Q33789473-86151CD1-069C-4912-A2E2-E7A2FB748D68

P478

Q33789473-8421EE58-CD88-4A66-ABAF-EAA748B2CBE8

P577

Q33789473-B9983D35-7EB4-4F78-B138-13D111B2C8B2

P698

Q33789473-D0FDB92E-FCE3-46F1-BEEC-9EDB0C5AE093

P921

Q33789473-22DD7521-D4D6-4970-B6F6-97E356A0EF47

P932

Q33789473-EED7370E-6A40-4126-BBE9-D03028D9F201

P1433

Restorative Neurology and Neuroscience

P1476

Peripheral markers of brain damage and blood-brain barrier dysfunction

@en

P2093

Andrew Kanner

http://www.w3.org/2001/XMLSchema#string

Barbara Ayumar

http://www.w3.org/2001/XMLSchema#string

Ben Albensi

http://www.w3.org/2001/XMLSchema#string

Damir Janigro

http://www.w3.org/2001/XMLSchema#string

Kelly Kight

http://www.w3.org/2001/XMLSchema#string

Marc R Mayberg

http://www.w3.org/2001/XMLSchema#string

Marco Cavaglia

http://www.w3.org/2001/XMLSchema#string

Miranda Kapural

http://www.w3.org/2001/XMLSchema#string

Nicola Marchi

http://www.w3.org/2001/XMLSchema#string

Peter Rasmussen

http://www.w3.org/2001/XMLSchema#string

P2860

The S100 protein family: history, function, and expression

Intraoperative values of S-100 protein, myelin basic protein, lactate, and albumin in the CSF and serum of neurosurgical patients

Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions

Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs.

Significance of early CT signs in acute stroke. A CT scan-diffusion MRI study.

Serum transthyretin monomer as a possible marker of blood-to-CSF barrier disruption.

The cell biology of the blood-brain barrier.

Manganese uptake and distribution in the central nervous system (CNS).

Blood-brain barrier, ion homeostatis and epilepsy: possible implications towards the understanding of ketogenic diet mechanisms.

Physiology and pathology of the blood-brain barrier: implications for microbial pathogenesis, drug delivery and neurodegenerative disorders.

P304

109-121

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

3-4

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14530574

http://www.w3.org/2001/XMLSchema#string

P921

blood–brain barrier

P932

4066375

http://www.w3.org/2001/XMLSchema#string